Donepezil Significantly Improves Abilities in Daily Lives of Female down Syndrome Patients with Severe Cognitive Impairment: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Donepezil Significantly Improves Abilities in Daily Lives of Female down Syndrome Patients with Severe Cognitive Impairment: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial

47

Citations

7

References

2011

Year

Tatsuro Kondoh, Atsushi Kanno, Hiroshi Itoh, Mikiro Nakashima, Ryoko Honda, Michio Kojima, Mitsuru Noguchi, Hideyuki Nakane, Hidetsugu Nozaki, Hitoshi Sasaki,

The International Journal of Psychiatry in Medicine

Abstract

Donepezil may effectively and safely improve overall functioning of DS patients with severe cognitive impairment.

References

	Year	Citations

Page 1